MMP9 and prostate carcinoma: Interestingly, while both bacterial neuraminidase and T. cruzi sialidase activate only MMP-2, the mammalian sialidase Neu-3, specific for SA α2,3 recognition observed in human prostate cancer models [69], is able to modulate both MMP-2 and MMP-9.